Document is current
Any future updates will be listed below
-
Authors
Chen, Chong-xiang https://orcid.org/0000-0002-2079-881X
Wang, Jiao-jiao
Li, Huan
Yuan, Le-tao https://orcid.org/0000-0002-1268-8135
Gale, Robert Peter https://orcid.org/0000-0002-9156-1676
Liang, Yang https://orcid.org/0000-0002-4226-9580
-
Funding
Funding for this research was provided by:
Guangdong Innovative and Entrepreneurial Research Team Program (2017ZT07S096)
- License Information
-
More Information
Article History
Received: 21 March 2021
Revised: 21 April 2021
Accepted: 26 April 2021
First Online: 14 May 2021
Compliance with ethical standards
:
: RPG is a consultant to BeiGene Ltd, Fusion Pharma LLC, LaJolla NanoMedical Inc., Mingsight Parmaceuticals Inc., and CStone Pharmaceuticals. Advisor: Antegene Biotech LLC, Medical Director: FFF Enterprises Inc. Partner: AZACA Inc. Board of Directors: RakFond Foundation for Cancer Research Support. Scientific Advisory Board, StemRad Ltd. All other authors declare no competing interests.
Free to read: This content has been made available to all.
